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Abstract
Autonomously replicating Bovine viral diarrhea virus (BVDV) genomes (replicons) were constructed from the full-length BVDV cDNA
clone pA/BVDV/Ins (G. Meyers et al., J. Virol. 70, 8606–8613, 1996). The sequences coding for envelope protein E2, for E2 without
the C-terminal transmembrane region, or for E2 and nonstructural protein p7 were deleted, and the resulting mutants were tested for their
ability to replicate after transfection. All deletion mutants were able to replicate and to express the inserted green fluorescent protein but
did not produce infectious progeny virus in bovine kidney PT cells. The replicons were also tested for their ability to be trans-complemented
in the bovine cell line PT_805, which constitutively expresses BVDV structural proteins. E2-negative BVDV mutants were complemented
and 106 infectious units were obtained at 24 h after transfection. Complementing PT_805 cells could only inefficiently be infected using
trans-complemented virions, however, and low levels of virus production were observed when complemented BVDV was passaged using
PT_805 cells. Similarly, infection of PT_805 cells with BVDV was highly inefficient, but transfection of full-length BVDV NCP7 RNA
into PT_805 resulted in 10,000-fold higher virus titers when compared to those obtained 24 h after transfection of parental PT cells. We
concluded that self-replicating E2-deleted BVDV RNAs can be efficiently trans-complemented by constitutively expressed E2, and that
expression of BVDV structural proteins markedly influences susceptibility of cells to BVDV infection as well as BVDV titers after
transfection of full-length BVDV RNA.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Bovine viral diarrhea virus (BVDV), a member of the
genus Pestivirus within the family Flaviviridae (van Regen-
mortel et al., 2000) is the causative agent of bovine viral
diarrhea, an economically important disease of cattle world-
wide (Brownlie et al., 1984; Houe, 1995). The major eco-
nomic losses caused by BVDV infections are reduced fer-
tility, abortions, and the generation of persistently infected
calves, which can develop fatal “mucosal disease” (Baker,
1995; Bolin, 1995; Moennig and Liess, 1995).
Genetically and structurally closely related virus species
are classical swine fever virus (CSFV) and the ovine border
disease virus (BDV) (van Regenmortel et al., 2000). Pesti-
viruses can be divided into two different biotypes, cyto-
pathogenic (cp) and non-cytopathogenic (ncp) viruses.
While cp BVDV induces apoptosis and cell death (Zhang et
al., 1996) and expresses nonstructural protein 3 (NS3) as
well as uncleaved NS2/3, inoculation with ncp BVDV leads
to persistent infection of cell cultures and expression of
NS2/3 (Donis and Dubovi, 1987). The pestivirus genome
consists of a single-stranded RNA of positive orientation.
The RNA has a length of approximately 12.3 kb and con-
tains one large open reading frame (ORF), which is flanked
by nontranslated regions (NTR) at both genome ends (Col-
lett et al., 1988a; Meyers et al., 1989). The pestiviral ORF
is translated into one polyprotein, which is co- and post-
translationally processed into 11 (ncp BVDV) or 12 (cp
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BVDV) mature proteins by viral and cellular proteases.
Pestivirus virions consist of four structural proteins, a capsid
(C) protein and three glycosylated envelope proteins (ERNS,
E1, E2) (Collett et al., 1991; Ru¨menapf et al., 1993; Donis,
1995). BVDV antibodies are directed against ERNS, E2, and
NS3 (Donis et al., 1991) and neutralizing activity was pre-
dominantly demonstrated for E2-specific antibodies (Donis
et al., 1988; Bolin, 1993). Envelope protein E2 is reported to
form a heterodimer with E1 as well as E2–E2 homodimers
(Weiland et al., 1990), and it has been suggested that E2
plays a major role in virus attachment and entry (Donis,
1995). On the basis of sequence analysis and determination
of the N-termini, it was shown that processing of E2 is
mediated by host cell signalase. Typical hydrophobic signal
sequences were identified upstream of the E2 N-terminus
within E1 and a transmembrane anchor of about 40 hydro-
phobic amino acids was demonstrated at the C-terminus of
E2 (Ru¨menapf et al., 1993).
Studies on the replication of BVDV have been consid-
erably facilitated by reverse genetic systems and the discov-
ery of autonomously replicating subgenomic RNAs (repli-
cons) (Behrens et al., 1998; Meyers et al., 1996). The
infectious BVDV clone of the cytopathogenic strain CP7 is
based on the plasmid pA/BVDV. Deletion of a genomic
insertion, which was shown to be responsible for cytopatho-
genicity, resulted in plasmid pA/BVDV/Ins. Using pA/
BVDV/Ins, the ncp BVDV strain NCP7 could be recov-
ered (Meyers et al., 1996). Furthermore, pA/BVDV and
pA/BVDV/Ins were used to define the first BVDV self-
replicating RNAs with genetic deletions similar to that of
so-called defective interfering particles (DI), e.g., DI9 tran-
scribed from pA/BVDV/D9 (Behrens et al., 1998; Meyers et
al., 1996; Tautz et al., 1999). Pestivirus self-replicating
RNAs are important tools for an understanding of virus
replication, assembly, and egress. So far, there are only a
few reports concerning BVDV replicons and trans-comple-
mentation of BVDV replicons. Grassmann et al. (2001)
trans-complemented defects in the nonstructural protein 5A
and Harada et al. (2000) characterized the E2-p7-coding
region using E2-p7-deleted replicons and complementing
cell lines. Trans-complementation of deleted parts of the
genome can be used for the identification of trans-acting
elements of the BVDV genome, but can also allow the
construction of a novel type of pestivirus vaccine using
complemented virions transferring defective genomes in
vivo. For CSFV, a set of self-replicating RNAs with various
deletions within the genome has been characterized (Moser
et al., 1999). Additionally, ERNS-deleted CSFV-replicons
were generated and trans-complemented using a swine kid-
ney cell line (SK6) constitutively expressing CSFV ERNS.
The resulting virions were able to infect SK6 cells without the
production of infectious virus progeny and could be passaged
on ERNS-expressing SK6 cells. Pigs were protected against
lethal CSFV challenge after immunization with these comple-
mented virions (Widjojoatmodjo et al., 2000).
The aims of this study were (i) the characterization of
novel self-replicating mutated BVDV RNA genomes (rep-
licons) and the investigation of their potency for expression
of foreign genes, and (ii) the attempt of efficient trans-
complementation of different replicons using a helper cell
line providing all structural BVDV proteins. We used the
infectious clone pA/BVDV/Ins to construct different
BVDV deletion mutants. The produced deletion mutants
were able to replicate and to express an inserted reporter
gene encoding green fluorescent protein (GFP), but did not
produce infectious progeny virus. By using a cell line consti-
tutively expressing all four BVDV structural proteins, two
different autonomously replicating E2 deletion mutants were
efficiently trans-complemented. The resulting virions were
able to infect bovine target cells and to transfer the replicons
without generating replication-competent virus progeny.
Results
Construction and characterization of BVDV replicons
After establishment of an infectious clone for BVDV
CP7 (plasmid pA/BVDV), a variant of the construct with a
deletion of a 27-nucleotide insertion was generated that
allowed recovery of ncp BVDV NCP7 (plasmid pA/BVDV/
Ins) (Meyers et al., 1996). Based on pA/BVDV/Ins,
several replicons were constructed by deletion of sequences
encoding E2 and p7 (Fig. 1). The replicons contained a
deletion of the complete E2 region (plasmid NCP7E2,
amino acids position 694 to 1066, Fig. 1), of the E2 gene
with an intact transmembrane region (tmr) where only the
ER lumenal part of E2 is deleted (NCP7E2lum, amino
acid position 694 to 1018, Fig. 1), or of the complete E2-p7
gene region (NCP7E2p7, amino acid position 694 to 1143,
Fig. 1). All deletions were confirmed by nucleotide se-
quencing of the resulting cDNA clones. Prototype replicon
DI9 transcribed from plasmid pA/BVDV/D9 (Behrens et
al., 1998; Meyers et al., 1996) and replication-defective
RNA transcribed from plasmid NCP73ntrAatII (Fig. 1)
were used as controls.
Subsequently, in vitro transcribed full-length replicon
RNA was transfected into BVDV-negative PT cells. Tran-
sient expression of NS2/3 and ERNS could be detected from
24 h posttransfection by immunofluorescence (IF) for all
replicons except NCP73ntrAatII (NS3 and ERNS-nega-
tive) and DI9 (ERNS-negative). However, no infectious re-
combinant BVDV could be recovered, even after serial
passages and copassages using highly susceptible KOP-R
cells (Table 1). The intensity of NS2/3-specific immuno-
staining of NCP7E2lum-, NCP7E2-, or NCP7E2p7-
transfected PT cells was comparable to cells transfected
with full-length NCP7 RNA and more than 85% of the cells
were positive in IF (Table 1, Fig. 2). Transfection of full-
length NCP7 RNA into PT cells resulted in virus titers of up
to 103 infectious units (IU)/ml 24 h posttransfection (p.t.).
As expected, electroporation of cells with RNA of the pro-
214 I. Reimann et al. / Virology 307 (2003) 213–227
totype replicon DI9 (Behrens et al., 1998) did not lead to
recovery of infectious BVDV, but a strong immunofluores-
cence following NS3 staining was observed. RT-PCR (Fig.
3A) and Northern blot analysis (Fig. 3B) of PT cells trans-
fected with NCP7 replicons and full-length NCP7 demon-
strated presence of BVDV-specific RNA of the expected
size containing the correct deletions. However, RNA bands
of the deletion mutants were weaker in Northern blot than
the bands of full-length NCP7 RNA and DI9 RNA (Fig.
3B). This observation was confirmed by repeated Northern
blot experiments (data not shown). No replication was de-
tectable after transfection of NCP73ntrAatII RNA (Fig.
3B). In summary, deleted BVDV genomes, which were
replication-competent but lacked the ability of generating
virus progeny, were constructed and could efficiently be
transfected into bovine cells.
Replicons of this kind are frequently used as expression
systems in mammalian cell lines. The feasibility of the
expression of foreign proteins by BVDV replicons was
examined by the insertion of the gene encoding the
GFP into the E2-p7-deleted replicon NCP7E2p7
(NCP7E2p7_GFP). After transfection of in vitro tran-
scribed NCP7E2p7_GFP RNA into PT cells, GFP fluo-
rescence could be detected in more than 80% of transfected
cells (Fig. 4A). Subsequent NS2/3 IF staining was positive
for a comparable number of cells (data not shown). Further-
more, RT-PCR analysis with NCP7-specific primers flank-
ing the E2-p7 region and with GFP-specific primers dem-
onstrated the correct insertion of the GFP gene (Fig. 4B). By
using NCP7E2p7_GFP, we were able to demonstrate ex-
pression of a foreign gene by an ncp BVDV replicon.
Establishment of a PT cell line expressing BVDV
structural proteins
To do complementation studies with the BVDV repli-
cons, a bovine cell line was established that constitutively
expresses BVDV structural proteins. PT cells were trans-
Fig. 1. Schematic representation of the generated constructs. Filled boxes represent the BVDV structural region. Horizontal dotted lines show the deleted
regions and numbers indicate the nucleotide position in the BVDV full-length RNA. Arrows indicate restriction enzyme sites flanking the deletions. Lines
at the left and right ends indicate untranslated regions. Npro, autoprotease; C, capsid protein; ERNS, E1, and E2, envelope proteins; p7, nonstructural protein;
N2 to NS5, nonstructural proteins, 3-NTR and 5-NTR, noncoding regions. The scale in kb is given.
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Table 1
Replication and trans-complementation of BVDV NCP7 RNAs with in-frame deletions (replicons)
Construct Replicationa after RNA
transfection in PT cells
(24 h)
1st passageb
(24 h, 48 h, 72 h)
on KOP-R cells
Titer of virus progenyc 24 h after
transfection of complementing
PT_805 cells (IU/ml)
4th passaged of virus
progeny on KOP-R
cells
NCP7  (P)e  (103 IU/ml) (P) 107.3 (P)  (P)
NCP7E2lum f øf 106.3 ø
NCP7E2  ø 106.6 ø
NCP7E2p7  ø 100 ndg
DI9  ø 100 nd
a PT cells were transfected with in vitro transcribed RNA and IF-stained for NS3 expression after 24 h.
b KOP-R cells were inoculated with undiluted supernatants 24, 48, and 72 h after transfection of PT cells (1 ml per 105 cells). KOP-R cells were stained
with NS3-specific mabs 5 days postinoculation.
c PT_805 cells were transfected with in vitro transcribed RNA and the supernatants were titrated after 24 h using KOP-R cells.
d KOP-R cells were inoculated using supernatants of transfected PT_805 cells with a titer  106 IU/ml (1 ml per 105 cells).
e P indicates the detection of virus plaques after NS3-staining (10 cells).
f ø  no BVDV-specific immunofluorescence;   weak positive NS3-IF-signal and 50% IF-positive cells,    positive NS3-IF-signal and 50%
IF-positive cells,   strong-positive NS3-IF-signal and 50% IF-positive cells.
g nd  not done.
Fig. 2. IF analysis of PT cells transfected with RNAs transcribed from NCP7E2lum (A), NCP7E2 (B), and NCP7E2p7 (C). At 24 h posttransfection,
NS2/3 expression was analyzed by IF using the mab mix WB103/105. Mock-transfected control cells remained NS2/3-negative (D).
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fected with plasmid pCDNA_C-E2, which contains the
complete region encoding the structural proteins C, ERNS,
E1, and E2 of ncp BVDV strain PT810 under the control of
the HCMV immediate early promotor, and a Neomycin/
Geneticin resistance gene allowing selection with G418.
After G418 selection and passaging, resistant cell clones
were tested for BVDV ERNS and E2 expression using mono-
clonal antibodies (mabs) WB210 and WB215, respectively.
Positive cells were cloned, passaged under G418 selection,
and tested again for ERNS and E2 expression. In the IF
analyses, G418-resistant cell clone PT_805 contained more
than 90% ERNS and E2 expressing cells (Fig. 5A). Confocal
microscopy indicated that ERNS and E2 are coexpressed in
PT_805 cells (Fig. 5B). During further passaging of PT_805
cells for 6 months in the presence of G418, the portion of
ERNS- and E2-expressing cells remained stable. Immuno-
precipitation experiments with an E2-specific antiserum
showed a protein pattern identical to that of BVDV-infected
PT cells, where glycoprotein E1 is coprecipitated with E2
(Fig. 6A). In addition, using Western blot analysis, expres-
sion of the envelope protein ERNS and the capsid protein
could be detected in lysates of PT_805 cells (Fig. 6B and
C). From these data and those obtained by nucleotide se-
quencing it was concluded that all BVDV structural proteins
were constitutively expressed in PT_805 cells. The cell line
was used for trans-complementation experiments and for
the generation of infectious virions as well as for packaging
and transducing deleted replicons.
Recovery and characterization of trans-complemented
recombinant BVDV
In vitro transcribed RNA of the replicons and of full-
length NCP7 was transfected into complementing PT_805
cells. At 24 h p.t., monolayers of PT_805 cells were exam-
ined for NS2/3 expression and culture supernatants were
passaged and titrated using highly susceptible KOP-R cells.
For all replicons and full-length NCP7, NS2/3 staining
following RNA transfection led to immunofluorescence pat-
terns similar to that obtained with PT cells. Between 30 and
95% of transfected cells were reactive with NS3-specific
antibodies (data not shown). Infectious recombinant BVDV,
however, was only detected in supernatants from PT_805-
cells transfected with NCP7E2lum, NCP7E2, or NCP7
RNA. Virus titers of the resulting complemented viruses
NCP7E2_trans and NCP7E2lum_trans varied between
106.3 and 106.6 IU/ml at 24 h p.t. (Table 1). After transfec-
tion of full-length NCP7 RNA into complementing PT_805
cells, virus titers of up to 107.3 IU/ml could be detected at
24 p.t. (Table 1). Therefore, titers of trans-complemented
viruses from supernatants collected at 24 h p.t. were ap-
proximately 10,000-fold higher than virus titers obtained at
24 h after transfection of full-length NCP7 RNA into non-
complementing PT cells (Table 1). In addition, no comple-
mented BVDV was detected after passaging of PT_805
cell-culture supernatants transfected with NCP7E2p7 or
DI9 replicon RNAs at all times p.t. (Table 1).
Using IF of KOP-R cells infected with NCP7E2_trans
and NCP7E2lum_trans, expression of ERNS (data not
shown) and NS2/3 but not E2 could be detected (Table 1,
Fig. 7). Expression pattern indicated that supernatants of
transfected PT_805 cells contained infectious virus that can
infect and replicate in KOP-R cells. Titration experiments
and subsequent IF staining demonstrated that no cell-to-cell
spread occurred, and that neither NCP7E2_trans nor
NCP7E2lum_trans were able to form NS2/3-positive
plaques or secondary infections in these cells (Table 1). At
higher dilutions, only single cells or small foci of cells were
positive by IF-staining for NS2/3. Control experiments with
Fig. 3. (A) RT-PCR analysis of selected replicons with primer pairs
flanking the E2-p7 region. RNA was extracted from 106 cells transfected
with transcribed RNA. All RT-PCR products were of the expected size
between 176 bp (NCP7E2p7) and 1528 bp (NCP7) and verified the
different deletions introduced into the E2 or E2-p7 region. (B) Northern
blot analysis of 10 g total RNA isolated from PT cells transfected with
the replicons DI9, NCP7E2lum, NCP7E2, NCP7E2p7, and the full-
length NCP7 RNA with a digoxigenin-labeled NS3 RNA probe. RNA from
cells transfected with the nonreplicating construct NCP73ntrAatll served
as a negative control. Arrows indicate the position in the gel of RNA of
12.3 kb (NCP7), 8 kb (DI9), and 2.3 kb (20 ng control RNA). For
semiquantitative analyses, RNA from DI9-transfected cells was used un-
diluted and at dilutions of 1:10 and 1:20. NCP7 and the deletion mutant
replicons demonstrated RNA in the correct size and with an amount in the
range of the diluted DI9 RNA.
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BVDV NCP7 on KOP-R cells resulted in antigen-positive
virus plaques as demonstrated for ERNS, NS2/3, and E2
(data not shown). The infection of KOP-R cells with trans-
complemented viruses could be blocked with BVDV-neu-
tralizing antisera (S-BVD_pos, S-BVD_E2) and no infec-
tivity was detected after inoculation of KOP-R cells (100%
neutralization). In a control reaction, incubation with a
BVDV antibody-free serum (S-BVD_neg) did not result in
virus neutralization (Table 2).
Surprisingly, infection of PT_805 cells with comple-
mented BVDV NCP7E2_trans or NCP7E2lum_trans at a
multiplicity of infection (m.o.i.) of 5 resulted in isolated
infection of only a few single cells as determined by IF
staining for NS2/3 at 24 h p.i. (Table 3, Fig. 8). Further-
Fig. 4. (A) Fluorescence analysis of GFP-expressing NCP7E2p7_GFP. Nearly 100% of cells transfected with in vitro transcribed RNA show GFP
fluorescence. (B) RT-PCR analysis of NCP7Ep7_GFP. RNA was extracted from PT cells 24 h posttransfection and used as template in an NCP7- and
GFP-specific RT-PCR, respectively. Arrows indicate the expected size of the PCR products of 891 bp with the E2-p7-flanking primer pair and of 716 bp with
the GFP primers.
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more, the number of infected PT_805 cells did not increase
by passaging of cells or supernatants or by prolonged incu-
bation times of up to 5 days (data not shown). Titration of
the resulting supernatants on KOP-R cells yielded constant
virus titers (single cells infected) of 101 to 102 IU/ml (Table
3). The titers of complemented viruses were independent
from both the incubation time and the passage level (data
not shown). As a control, PT_805 cells were infected using
BVDV strain PT810 or NCP7 at an m.o.i. of 5. Here, also
only single cells were positive after NS3-specific IF staining
at 24 h p.i. In addition, virus plaques could be detected using
IF-staining after more than 48 h postinfection of PT_805
cells (Fig. 8). Original PT cells, however, which were in-
oculated with the same virus preparation, could be easily
infected with BVDV PT810 and NCP7 (plaque formation
demonstrated using IF staining; Fig. 8) or complemented
NCP7E2_trans and NCP7E2lum_trans viruses (no
plaque formation, data not shown). The reason for this
nonpermissiveness of PT_805 cells expressing BVDV
structural proteins remains to be determined.
Discussion
Pestivirus genomes with deletions were first described as
defective interfering particles for BVDV and CSFV (Kup-
fermann et al., 1996; Meyers and Thiel, 1995), and auton-
omous replication of such defective genomes was demon-
strated (Behrens et al., 1998; Moser et al., 1999; Tratschin
et al., 1998). From these experiments it became obvious that
neither the BVDV nonstructural proteins Npro, p7, NS2, nor
the structural proteins are essential for BVDV RNA repli-
cation. In addition, defective interfering particles were reported
to be packaged by helperviruses (Kupfermann et al., 1996).
Here, we constructed NCP7 mutants with deletions of E2
(with or without transmembrane region) or E2-p7 without
Fig. 5. (A) IF analysis of the cell line PT_805 expressing the structural proteins C, ERNS, E1, and E2 of BVDV strain PT810. Both staining with an E2-specific
mab (WB215) and with an ERNS-specific mab (WB210) led to positive signals in virtually all cells. IF analysis with a NS3-specific mab (C16) as well as
staining of the parental cell line PT gave a negative result (data not shown). (B) Confocal analysis of double immunofluorescence in PT_805 cells stained
for ERNS and E2. Acetone-fixed PT_805 cells were stained with the monoclonal antibodies WB215 (anti-E2; IgG2b) and WB210 (anti-ERNS; IgG1). Binding
of the mabs was detected using type-specific anti-mouse conjugates labeled with Cy3 (anti-IgG1) or FITC (anti-IgG2b). Analysis of the double-stained cell
cultures using confocal laser scanning microscopy (LSM510, Zeiss, Germany) clearly demonstrated that E2-expressing cells (green staining) were also
positive for the expression of ERNS (red staining). The yellow color in the superimposed picture indicated a colocalization of the two stained proteins.
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introducing a frameshift within the BVDV ORF. Trans-
fection of in vitro transcribed RNA of the replicons
NCP7E2lum, NCP7E2, and NCP7E2p7 resulted in
RNA replication. In all experiments, the prototype replicon
DI9 (Meyers et al., 1996) and a replication-defective
NCP73ntrAatII deletion mutant served as controls. In
none of the cases was virus progeny detectable after pas-
saging of the supernatants of cells transfected with the
deletion mutants. However, virus progeny with a titer of
approximately 102 to 103 IU/ml could be detected at 24 h
after transfection of full-length BVDV NCP7 RNA in su-
pernatants of transfected PT cells. Recently, it was shown
that p7 is essential for formation of infectious BVDV
(Harada et al., 2000). Although deletion of p7 alone pre-
vented generation of infectious viruses, Harada et al. (2000)
could further demonstrate that a cell line expressing both p7
and E2, but not p7 alone, could rescue the E2-p7-deleted
replicon. It can be concluded from these data that E2 is
essential for infectious virion production. Our experiments
with NCP7E2lum and NCP7E2 now provide direct ev-
idence for the essential nature of E2. In addition, our data
confirm that p7 is essential, since the E2p7 deletion could
not be trans-complemented with PT_805 cells. After rein-
sertion of the gene coding for E2, the resulting revertant
NCP7revE2 BVDV was indistinguishable from original
NCP7 (data not shown). Furthermore it was shown that
deletion of E2-p7, E2, or E2lum did not severely impact the
ability of RNA self-replication. Nevertheless, Northern blot
analysis of the replicons argues for a better RNA replication
with full-length NCP7 and prototype replicon DI9 than with
the deletion mutants. In a series of CSFV deletion mutants
(Moser et al., 1999), replicons with different levels of au-
tonomous RNA replication were also detected, and some of
the reported mutants were not replication competent.
After in-frame insertion of a GFP-coding gene into the
E2 locus of the NCP7E2p7 deletion mutant, the resulting
construct NCP7E2p7_GFP was shown to replicate after
RNA transfection into PT cells and to express the inserted
reporter gene. Expression of foreign genes using self-repli-
cating RNAs is well known for members of the genus
Alphavirus (e.g., Sindbis virus replicons), where expression
is driven by a subgenomic promotor (Schlesinger and
Dubensky, 1999), and in the family Flaviviridae in the case
of the Kunjin virus replicon (Varnavski and Khromykh,
1999). The novel non-cytopathogenic BVDV replicon vec-
tor expressing GFP allows the convenient visualization of
replicons, independent from fixation and IF staining. Fur-
thermore, self-replicating BVDV RNAs may be used for
long-term expression of other foreign proteins, especially in
ruminant cell lines and possibly in ruminants, e.g., after
trans-complementation of virions. The reported transfection
efficiency and the noncytopathic characteristics could make
BVDV replicons a useful expression system not only for
bovine cells, but also for other mammalian cell lines.
Trans-complementation of structural proteins has been
reported for CSFV (Widjojoatmodjo et al., 2000), BVDV
(Harada et al., 2000), and Kunjin virus (Khromykh et al.,
1998). In addition to complementation by helper viruses, the
Fig. 6. (A) Immunoprecipitation of E2 and E1 from PT_805 cells. Controls (parental PT cells) and PT_ 805 cells were labeled with [35S]methionine-cysteine
and collected after 16 h. Extracts were analyzed by immunoprecipitation with an anti-E2 rabbit serum, and precipitates were subject to SDS–PAGE (10%
acrylamide) under reducing conditions. Bands representing the BVDV proteins E2, E2-E1, and coprecipitated E1 could be detected in comparison to the
control cells. Sizes are indicated in kilodaltons. (B) Western blot analysis of PT_805 cells using a mix of anti-ERNS mabs WB210 (1:100 dilution) and 01-03
(1:500 dilution). Lysates of PT_805 and PT cells were subject to SDS–PAGE (12% acrylamide) and subsequent protein transfer to a nitrocellulose membrane.
ERNS protein with a size of about 48 kDa could be detected in comparison to the parental PT cell line. Sizes are indicated in kilodaltons. (C) Western blot
analysis of PT_805 cells using an anti-capsid rabbit serum (kindly provided by Tillmann Ru¨menapf, Giessen, Germany). Lysates of PT_805 and PT cells
were subject to SDS–PAGE (10% acrylamide) and subsequent protein transfer to a nitrocellulose membrane. Capsid protein with a size of about 14 to 16
kDa could be detected in PT_805 cells using the anti-capsid serum and an anti-rabbit HRP-conjugate. Sizes are indicated in kilodaltons.
220 I. Reimann et al. / Virology 307 (2003) 213–227
221I. Reimann et al. / Virology 307 (2003) 213–227
missing gene products were also provided by Semliki Forest
virus replicons or cell lines constitutively expressing the
deleted structural proteins. For the here-described trans-
complementation of BVDV replicons, self-replicating
RNAs were directly transfected into the bovine cell line
PT_805 expressing the structural proteins C, ERNS, E1, and
E2 of BVDV. After transfection into PT_805 cells, repli-
cons with deletions of the E2 sequence (NCP7E2lum and
NCP7E2) were efficiently complemented in trans. The
resulting virus titers of about 5	 106 IU/ml as early as 24 h
after transfection noticeably exceeded those reported for the
parental NCP7 clone (Meyers et al., 1996) and other com-
plemented BVDV (Harada et al., 2000). To our knowledge,
this is the first report of a highly efficient complementation
of BVDV E2 deletion mutants and the first report of a
bovine cell line constitutively expressing all structural pro-
teins of BVDV. Transfection of full-length BVDV NCP7
RNA into PT_805 cells also resulted in 10,000-fold higher
virus titers compared to virus titers obtained 24 h after
transfection of NCP7 RNA into parental PT cells. One
possible explanation could be that the presence of additional
BVDV structural proteins in PT_805 cells enhanced assem-
bly and/or egress of infectious virions. An early and more
efficient packaging of full-length RNA in the presence of
“excess” structural proteins may be responsible for this
phenomenon. In this context, it is noted that previous re-
ports also describe low virus yields at 24 h after transfection
of RNA transcribed from pA/BVDV/Ins (Meyers et al.,
1996). In addition, virus titers of less than 103 TCID50/ml
were reported for the infectious cDNA clone of cp BVDV
strain NADL during the first 48 h p.t. (Vassilev et al., 1997).
However, since NCP7 titers reach levels similar to that of
other BVDV strains after replication for several days (Mey-
ers et al., 1996), it is also possible that the structural proteins
provided by the PT_805 cell line compensate for a general
defect at the early phase of BVDV assembly and egress.
Selection of a cell clone which is more permissive to BVDV
replication is extremely unlikely due to the fact that an
independently constructed second cell line (PT_803) ex-
pressing all BVDV structural proteins showed the same
characteristics (data not shown). Further experiments with
additional infectious cDNA clones and cell lines providing
only single structural proteins (e.g., E2) are in progress.
Infection of noncomplementing bovine cells with the
trans-complemented viruses resulted in replication without
release of infectious virus particles. Such complemented
virions were indistinguishable from wild-type BVDV in
virus neutralization experiments and were completely neu-
tralized by a BVDV-specific serum as well as by a BVDV
E2-specific serum. Recombinations yielding infectious
wild-type BVDV were not detected in any of the comple-
mentation experiments. Even after four consecutive pas-
sages on highly susceptible KOP-R cells, no rescued BVDV
was seen in transfection supernatants containing more than
106 IU/ml trans-complemented virions (Table 1). However,
homologous RNA recombination is a possible risk for plus-
stranded RNA viruses in general (Hill et al., 1997;
Schlesinger and Weiss, 1994). RNA recombination was also
described for wild-type BVDV in persistently infected cattle
following application of a modified live BVDV vaccine
(Becher et al., 1999) or after experimental inoculation
(Fritzemeier et al., 1995), but the incidence seems to be very
low, because similar complementation experiments using
CSFV replicons with deletions in the ERNS-coding region
did not result in replication-competent recombinants, even
after 10 serial passages of the defective viruses using an
ERNS-expressing cell line (Widjojoatmodjo et al., 2000).
While CSFV ERNS-expressing SK6 cells allowed infection
with complemented virions (Widjojoatmodjo et al., 2000), a
markedly reduced susceptibility of complementing PT_805
cells to BVDV infection could be demonstrated. Only single
virus foci were observed following BVDV PT810 or NCP7
inoculation using an m.o.i. of 5. The cells, however, could
efficiently replicate BVDV, since transfection of full-length
NCP7 RNA into the complementing cells led to high BVDV
titers at 24 h p.t. Harada et al. (2000) reported a BVDV
E2p7- and a p7-expressing cell line, which could not be
infected with BVDV. The observed phenomenon is referred
to as virus interference, but the mechanisms leading
to interference are not well understood. Probably as a
consequence of the interference, complemented virions
NCP7E2_trans and NCP7E2lum_trans could not be pas-
saged using PT_805 cells. In contrast, complemented CSFV
Fig. 7. IF analyses of trans-complemented viruses. PT_805 cells were transfected with replicon RNA and supernatants were harvested at 24 h p.t. for
inoculation of KOP-R cells. At 24 h p.i., KOP-R cells were analyzed by IF using NS3- and E2-specific monoclonal antibodies (WB103/105; WB215).
Infectious virions could be passaged from supernatants of PT_805 cells transfected with NCP7, NCP7E2lum, and NCP7E2 (Fig. 7A, B, and C), but not
from NCP7E2p7- or DI9-transfected PT_805 cultures (Fig. 7D, E, I, and J). An E2 expression (mab CA3) could only be detected in cells inoculated with
supernatants from PT_805 cells transfected with full-length NCP7 RNA (Fig. 7F, G, and H).
Table 2
Neutralization of wild-type and complemented BVD viruses by BVDV-
specific antisera
BVDVa IF analysis 3 days postinoculation of the
neutralization mix
S-BVD_posb S-BVD_E2c S-BVD_negd
NCP7 ø ø e
NCP7E2lum_trans ø ø 
NCP7E2_trans ø ø 
a Complemented viruses were adjusted to a titer of 104 IU/ml.
b Cattle serum prepared against BVDV type 1.
c Sheep serum specifically directed against BVDV type 1 E2.
d BVDV antibody free cattle serum.
e ø  no IF-positive cells,   more than 100 IF-positive cells/well.
222 I. Reimann et al. / Virology 307 (2003) 213–227
replicons with a deletion in the ERNS-coding region could be
efficiently propagated using CSFV ERNS-expressing SK6
cells and there is a reported increase of the titers of com-
plemented CSFV during passaging (Widjojoatmodjo et al.,
2000). Nevertheless, our results demonstrate that BVDV
structural proteins can play a role in the blocking of super-
infection, and that BVDV envelope protein E2 may be a
candidate causing the described form of interference.
In summary, we were able to demonstrate trans-comple-
mentation of self-replicating E2-deleted BVDV RNAs and
enhancement of BVDV replication using a bovine cell line
expressing all BVDV structural proteins. The described
trans-complemented BVDV as well as the helper cell line
PT_805 may open new ways to study pestivirus entry,
packaging, release, and interference. Furthermore, comple-
mented BVDV may be useful for the development of safe
and efficient BVDV vaccines.
Materials and methods
Cells
PT cells (RIE11 CCLV), a permanent bovine kidney cell
line, and KOP-R cells (RIE244, CCLV), a diploid bovine
esophageal cell line, were obtained from the collection of
cell lines in veterinary medicine at the Federal Research
Center for Virus Diseases of Animals, Insel Riems (CCLV).
Cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% BVDV-free fetal bovine
serum (FBS). PT cells were chosen due to their applicability
for DNA/RNA transfection and for generation of constitu-
tively expressing cell lines. KOP-R cells were selected due
to their susceptibility to BVDV infection and their suitabil-
ity for BVDV propagation.
Monoclonal antibodies, BVDV antisera, and BVDV
neutralization
For the detection of BVDV proteins, mab WB210 (IgG1,
anti-ERNS, CVL, Weybridge), 01-03 (anti-ERNS, kindly pro-
vided by Christian Schelp, Intervet BV) WB215 (IgG2b,
anti-E2, CVL, Weybridge), CA3 (anti-E2, Institute for Vi-
rology, TiHo Hannover), mab-mix WB103/105 (anti-NS3,
CVL, Weybridge), and C16 (anti-NS3, Institute for Virol-
ogy, TiHo, Hannover) were used (Edwards et al., 1988,
1991; Peters et al., 1986). IF analysis using a fluorescence-
activated cell sorter (FACS; Becton–Dickinson) was per-
formed as previously described (Grummer et al., 2001).
Cells were detached with a trypsine solution, fixed with 1%
paraformaldehyde (PFA; Sigma) on ice for 15 min, and
permeabilized for 5 min with 0.0025% digitonin (in PBS;
Sigma) at room temperature. After two washing steps with
phosphate-buffered saline without Ca/Mg (PBS),
BVDV-specific mabs were added for 15 min. Binding of the
mabs was detected using ALEXA488 goat anti-mouse con-
jugate (Molecular Probes). Stained cells were resuspended
in 100 l propidium iodide (PI; Sigma) solution and ana-
lyzed by flow cytometry (5000 cells/sample). For IF anal-
ysis using a fluorescence microscope or a confocal laser
scanning microscope (CFM), cell cultures were fixed with
3% PFA and permeabilized with 0.0025% digitonin (stain-
Table 3
Infection of PT_805 cells with BVDV strains PT810 or NCP7 or
complemented viruses
IF staining (NS3) and titration after
infection of PT_805 cells
BVDV PT810 or NCP7a Single plaquesb
NCP7E2lum_trans Single cellsc (101–102 IU/ml)
NCP7E2_trans Single cells (101–102 IU/ml)
a PT_805 cells were inoculated with BVDV PT810, NCP7, or comple-
mented viruses in 24-well plates at an m.o.i. of 5.
b More than five neighboring cells were NS3-positive.
c Single cells or pairs of cells were NS3-positive, no virus plaques.
Fig. 8. Immunofluorescence analysis of PT_805 cells 48 h after infection with BVDV NCP7 or NCP7E2_trans (m.o.i. 5). Only single cells
(NCP7E2_trans) or single virus plaques (NCP7) could be detected following IF staining with NS3-specific mab C16. In contrast, simultaneous infection
of PT cells with NCP7 resulted in nearly 100% IF-positive cells.
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ing of NS2/3) or fixed/permeabilized using 80% acetone
(staining of E2 or ERNS). Subsequently, cell cultures were
incubated with the working dilution of the appropriate mabs
for 15 min. After two washing steps with PBS, cultures
were incubated with an anti-mouse Ig ALEXA488 conjugate
for 15 min and finally washed and analyzed using a fluo-
rescence microscope (Olympus). For double staining, the
protein-specific mabs were detected with type-specific
FITC-(anti-mouse IgG2b, Medac, Germany) or Cy3-labeled
(anti-mouse IgG1, Medac, Germany) conjugates. Double-
stained cell cultures were analyzed using confocal laser
scanning microscopy (Zeiss, LSM510).
BVDV was neutralized with a pooled anti-BVDV serum
(S-BVD_pos), which was collected from cattle experimen-
tally infected with ncp BVDV strain PT810 (Beer et al.,
2000). The homologous neutralization titer of this serum
was 1:4096. For E2-specific neutralization, serum from
sheep, immunized with an E2-expressing modified Vaccinia
Virus Ankara (MVA), was used (S-BVD_E2) (Beer et al.,
unpublished data). A BVDV antibody-free cattle serum
(S-BVD_neg) served as a control. For neutralization of
BVDV, 100 l of virus suspension (104 TCID50/ml) was
mixed in a 24-well plate with 50 l of undiluted serum and
incubated at 37°C. After 2 h, KOP-R cells (2 	 104) were
transferred to the mixture and incubated for 3 days at 37°C.
Subsequently, the monolayer was stained for BVDV-NS2/3
by indirect immunofluorescence (Grummer et al., 2001).
Radioimmunoprecipitation
PT_805 cells (1.5 	 106) were labeled with 35S-protein
cell-labeling mixture (Amersham Pharmacia Biotech). In
brief, cell-culture medium was replaced with DMEM with-
out methionine and cysteine (Gibco) and incubated for 60
min at 37°C. Subsequently, the cells were labeled with 100
Ci of 35S-protein cell-labeling mixture for 16 h at 37°C,
washed twice with PBS, and lysed with RIPA buffer [1%
Triton X-100, 10 mM sodium phosphate (pH 7.1), 1%
sodium desoxycholate, 0.1% SDS, 40 mM sodium fluoride,
10 mM EDTA, and 1 g/ml Aprotenin]. The lysate was
clarified by centrifugation at 40,000 g for 30 min and sub-
jected to radioimmunoprecipitation analysis. The clarified
lysates were incubated with an E2-specific rabbit serum for
60 min with rocking. Pansorbin cells (Calbiochem) were
added and incubated for 1 h at 4°C with rocking. Immuno-
precipitates were washed three times with RIPA wash
buffer [0.3% Triton X-100, 1 M NaCl, 10 mM sodium
phosphate (pH 7.1), 10 mM EDTA] and then washed finally
with RIPA wash buffer lacking Trition X-100. Washed
immunoprecipitates were resuspended in sample buffer,
heated to 95°C for 5 min, and centrifuged at 12,000 g for 1
min. Immunoprecipitated proteins were separated by so-
dium dodecyl sulfate–10% polyacrylamide gel electro-
phoresis (SDS–PAGE) under reducing conditions and ex-
posed to X-ray film for 48 h.
Western blot
PT_805 cells (1.5	 106) were lysed by adding 300 l of
lysis buffer [1% Triton X-100, 20 mM sodium phosphate
(pH 7.1), 150 mM NaCl, 2 mM EDTA]. The cell lysate was
cleared of cell debris by low-speed centrifugation at 10,000
g for 5 min. For separation of proteins, 20 l of lysate was
electrophoresed through a 10 or 12% SDS–PAGE and then
proteins were transferred onto a nitrocellulose membrane
(Schleicher & Schu¨ll). The membrane was incubated for 1 h
at room temperature with a mix of anti-ERNS mabs WB210
(1:100 dilution) and 01-03 (1:500 dilution) or a capsid
antiserum (kindly provided by Tillmann Ru¨menapf, Univer-
sity of Giessen, Germany; 1:10,000 dilution) in TBST
buffer (20 mM Tris–HCl, pH 7.5; 150 mM NaCl, 0.1%
Tween 20). After washing with TBST buffer, the membrane
was incubated at room temperature for 1 h with an anti-
mouse (Dianova; 1:30,000 dilution) or an anti-rabbit (Di-
anova; 1:20,000 dilution) horseradish conjugate. Following
washing, the membrane was incubated with SuperSignal
chemiluminescent detection reagent (Pierce) and exposed to
film.
In vitro transcription and electroporation
In vitro transcription of linearized full-length cDNA con-
structs and replicons was performed by T7 RiboMax Large-
Scale RNA Production System (Promega) according to the
manufacturer’s instructions. The amount of RNA was esti-
mated by ethidium bromide staining after agarose gel elec-
trophoresis. For transfections, 1 	 107 PT, PT_805, or
KOP-R cells were detached using a trypsine solution,
washed with PBS, mixed with 1–5 g of in vitro synthe-
sized RNA, and electroporated (two pulses at 850 V, 25 F,
156 ) using an EasyjecT Plus (EquiBio) transfection unit.
Establishment of C-ERNS-E1-E2 expressing PT cells
The genomic region encoding the structural proteins (C-
ERNS-E1-E2) of ncp BVDV strain PT810 (Wolfmeyer et al.,
1997) was cloned as a chemically synthesized synthetic
open reading frame (Syn-ORF; kindly provided by Tobias
Schlapp, Bayer AG, Leverkusen). It consisted of 2694 nu-
cleotides extending from nucleotide 890 to 3584 of the
nucleotide sequence of BVDV strain NADL (Collett et al.,
1988b) and was inserted into the pcDNA3.1 expression
plasmid (Invitrogen) using restriction sites KpnI and NotI.
The pcDNA3.1 plasmid allows the efficient expression of
proteins under control of the HCMV immediate early pro-
motor/enhancer. Stable cell lines can be selected with G418
(Gibco, Life Technologies) using the Neomycin/Geneticin
resistance gene. The nucleotide sequence of Syn-ORF had
been changed to remove splice sites (Schmitt et al., 1999),
but retained the original amino acid sequence of ncp BVDV
strain PT810 (Accession No. AY078406). Additionally, the
first codon of Syn-ORF was changed to a methionine to
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allow expression of the polyprotein under the control of the
HCMV immediate-early promotor present in pcDNA3.1,
and a stop codon was inserted behind the last codon. The
resulting construct pCDNA_C-E2 (1 g) was used to trans-
fect PT cells with the SUPERFECT reagent (Qiagen). At 2
days after transfection, cell-culture medium was changed to
DMEM supplemented with 10% bovine serum and 1 mg of
G418 per milliliter. G418-resistant colonies were isolated,
replated several times, and stained for ERNS and E2 expres-
sion using mabs WB210, WB215, and CA3.
Polymerase chain reaction (PCR) and sequencing
For PCR, a PTC-200 thermal cycler (MJ Research, Inc.)
was used. DNA-based amplification was done by Expand
High-Fidelity PCR System (Roche Molecular Biochemi-
cals) according to the supplier’s protocol. Primers for gen-
eration of the respective constructs are summarized in Table
4. For RT-PCR, total RNA of virus-infected cells was ex-
tracted using the TRIZOL reagent (Gibco-Life Technolo-
gies). cDNA was amplified from the RNA template by using
reverse transcriptase (AMV; Promega) and a sequence-spe-
cific primer. The synthesized cDNA was amplified with a
thermostable Taq Polymerase (Promega) and PCR products
were directly sequenced. RNA for RT-PCR experiments
was treated with RNase-free DNases and the RT step was
omitted to detect contamination with cDNA. Replication
defective NCP73ntrAatII served as a negative control.
Sequencing was carried out using a Thermo Sequenase
Cycle Sequencing Kit (Amersham Biosciences). Nucleotide
sequences were read with a LI-COR automatic sequencer
(MWG Biotech) and were analyzed using the Wisconsin
software package version 9.1 (Genetics Computer Group,
USA).
RNA analysis
Total RNA for Northern blot analysis was extracted from
5 	 106 electroporated cells by using TRIZOL (Gibco-Life
Technologies). Five to ten micrograms of RNA were sepa-
rated using a denaturating 1% agarose gel. RNA transfer,
hybridization, and chemiluminescent detection were per-
formed following standard supplier protocols (Roche Mo-
lecular Biochemicals). Using a DIG-labeled riboprobe,
which is complementary to nucleotides 5153 to 5774 of the
BVDV genome, the detection of positive-stranded replicon
RNA or of BVDV NCP7 RNA (Accession No. U63479)
was done. As a negative control, replication-defective RNA
transcribed from NCP73ntrAatII (Table 4) was trans-
fected.
Plasmid constructs
Plasmids were amplified in Escherichia coli TOP10F
cells (Invitrogen). Restriction enzyme digestion and cloning
procedures were performed according to standard protocols.
Plasmid DNA was purified by Qiagen Plasmid Mini, Midi,
or Maxi kits. The primers used for PCR or sequencing
(labeled with IRD 800) were custom synthesized (MWG-
Biotech). Primer pairs for the construction of deletion mu-
tants are given in Table 4. The full-length BVDV cDNA
clone pA/BVDV/Ins and the DI9 cDNA construct pA/
BVDV/D9 have been previously described (Meyers et al.,
1996). Mutant BVDV clones shown in Fig. 1 were con-
structed on the basis of the full-length cDNA clone pA/
BVDV/Ins. Location of restriction sites are indicated by
superscript numbers corresponding to their cleavage posi-
tions in the BVDV CP7 genome (Fig. 1, Table 4). The used
KpnI restriction sites almost exactly span the NCP7 E2p7
region. However, nucleotides coding for one amino acid
from E2 remained and a genomic region coding for the first
six amino acids of NS2 was additionally deleted following
KpnI digestion and ligation.
For construction of NCP7E2p7 and NCP7E2p7_GFP,
plasmid pA/BVDV/Ins was digested with KpnI2447,3797
and re-ligated. The in-frame deletion comprised E2 and p7
sequences. To establish a GFP-expressing replicon, a PCR
fragment of plasmid pEGFP-N1 (Clontech Laboratories)
was amplified with appropriate primers GFP_KpnI and GF-
PR_KpnI, digested with KpnI, and ligated in-frame into
KpnI-digested plasmid NCP7E2p7 (Fig. 1, Table 4). The
NCP7E2 and NCP7E2lum plasmids (lum: ER lumenal
region of E2, without the transmembrane region) were con-
structed by inserting a PCR fragment containing the p7
sequence (primers p7 and p7R; BVDV CP7 nt 3567–3785)
or the tmrp7 sequence (primers p7 and tmr-E2; BVDV CP7
Table 4
PCR primers used for plasmid construction
Primer Sequence (5 to 3)a Genomic region in
BVDV CP7 (nucleotides)
GFP-Kpnl CAAGGGTACCCAATGGTGAGCAAGGGCGAGGAG  (sense)
GFPR-Kpnl TCTAGGTACCCCTTGTACAGCTCGTCCATGCC  (sense)
p7 CAAGGGTACCCAGTCCAGTATGGGGCAGGTGA 3567–3586 (sense)
p7R GCTCTAGGTACCCCTGGGCA 3785–3804 (sense)
tmr-E2 CAAGGTACCCATGGTTTGACCTAGAGATCAC 3423–3442 (sense)
a Restriction enzyme sites are underlined; overlaps to facilitate restriction enzyme digestion are in italics, and additional nucleotides for in-frame ligation
or generation of translation start codons are in bold.
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nt 3423–3785) into the KpnI2447 site of plasmid
NCP7E2p7 (Fig. 1, Table 4). For construction of
NCP73ntrAatII plasmid pA/BVDV/Ins was digested
with AatII and Klenow DNA polymerase. After re-ligation,
deletion of nucleotides 12,242 to 12,245 was confirmed by
sequencing (Fig. 1). Further details of the plasmid construc-
tion, including single cloning steps, are available on request.
Complementation experiments
For trans-complementation experiments, in vitro tran-
scribed BVDV replicon RNA was transfected into PT_805
cells by electroporation. Cell-culture supernatants were col-
lected 24 to 72 h p. t., clarified by centrifugation (10,000 g,
5 min), and titrated using KOP-R cells. At the day of
collection, replication of BVDV was monitored by IF stain-
ing.
Virus titers of the complemented viruses were deter-
mined as infectious units. Cell-culture supernatants were
titrated in triplicate in log10 steps and 1 ml was inoculated
onto KOP-R cells seeded in 24-well plates. After 12 h of
incubation at 37°C, cells were washed, detached with a
trypsin solution, and counted. An aliquot of the cells was
stained by IF using a BVDV NS3-specific mab and ana-
lyzed by flow cytometry. Infectious units were calculated
according to the formula:
Number of cells in the well	% IF-positive cells
	 dilution factor titer in IU/ml
For calculations, only wells with 5 and 30% IF-positive
cells were considered.
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